Utah Medical Products, Inc. (UTMD)

Utah Medical Products Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	38.83	40.9	50.22	52.28	49.05	42.18
Revenue Growth (YoY)	-16.64%	-18.56%	-3.94%	6.58%	16.30%	-10.08%
Cost of Revenue	16.57	16.76	20.19	20.09	18.14	16.63
Gross Profit	22.26	24.14	30.04	32.2	30.92	25.55
Selling, General & Admin	7.71	7.6	11.04	11.91	11.51	11.35
Research & Development	0.58	0.81	0.56	0.49	0.53	0.49
Operating Expenses	8.29	8.41	11.6	12.41	12.04	11.84
Operating Income	13.97	15.73	18.44	19.79	18.88	13.71
Interest & Investment Income	3.37	3.37	3.04	0.66	0.17	0.11
Currency Exchange Gain (Loss)	-0.01	0	-0.01	-	-	-
Other Non Operating Income (Expenses)	-0.5	-0.16	0.28	0.21	0.02	0.02
EBT Excluding Unusual Items	16.83	18.94	21.75	20.66	19.06	13.84
Legal Settlements	-1.35	-2.14	-1.66	-	-	-
Pretax Income	15.49	16.8	20.09	20.66	19.06	13.84
Income Tax Expense	2.93	2.93	3.45	4.19	4.27	3.04
Net Income	12.55	13.87	16.64	16.47	14.79	10.8
Net Income to Common	12.55	13.87	16.64	16.47	14.79	10.8
Net Income Growth	-19.68%	-16.60%	0.98%	11.39%	36.95%	-26.68%
Shares Outstanding (Basic)	3	4	4	4	4	4
Shares Outstanding (Diluted)	3	4	4	4	4	4
Shares Change (YoY)	-7.08%	-3.68%	-0.16%	-0.46%	-0.33%	-1.79%
EPS (Basic)	3.74	3.96	4.58	4.53	4.05	2.95
EPS (Diluted)	3.74	3.96	4.57	4.52	4.04	2.94
EPS Growth	-13.63%	-13.42%	1.20%	11.88%	37.41%	-25.36%
Free Cash Flow	-	14.6	21.64	20.34	20.65	19.28
Free Cash Flow Per Share	-	4.17	5.95	5.58	5.64	5.25
Dividend Per Share	1.215	1.205	1.185	1.165	0.855	1.120
Dividend Growth	1.67%	1.69%	1.72%	36.26%	-23.66%	1.82%
Gross Margin	57.33%	59.03%	59.81%	61.58%	63.03%	60.57%
Operating Margin	35.98%	38.46%	36.71%	37.85%	38.49%	32.50%
Profit Margin	32.33%	33.92%	33.12%	31.51%	30.15%	25.60%
Free Cash Flow Margin	-	35.70%	43.09%	38.90%	42.10%	45.70%
EBITDA	16.83	18.53	24.75	26.82	26.16	20.88
EBITDA Margin	43.35%	45.30%	49.28%	51.30%	53.33%	49.50%
D&A For EBITDA	2.86	2.8	6.32	7.03	7.28	7.17
EBIT	13.97	15.73	18.44	19.79	18.88	13.71
EBIT Margin	35.98%	38.46%	36.71%	37.85%	38.49%	32.50%
Effective Tax Rate	18.93%	17.43%	17.19%	20.26%	22.42%	21.98%

Updated Jul 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q